Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Jul 08, 2014 11:00 AM - Jul 08, 2014 12:30 PM

Online

Seven-Part Series on Pediatric Drug Development - Part 4: Dosing in Children

Speakers

Klaus  Rose, MD, MS

Klaus Rose, MD, MS

Chief Executive Officer, klausrose Consulting, Switzerland

Klaus Rose, a German MD with postgraduate degrees in General & Pharmaceutical Medicine, was 20 years with Big Pharma. In 2001, he became Global Head Pediatrics at Novartis & 2005 at Roche ; CEO of klausrose Consulting since 2011. He advises on pediatric drug development and FDA/EMA pediatric requirements. Private interests: languages, classical guitar, cooking, wine & gardening

Adina Valeria Tocoian, MD

Adina Valeria Tocoian, MD

, F.Hoffmann-La Roche Ltd, Switzerland

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.